The effects of phosphorylated ERK1/2 on PCa cells can be particularly the enhancement of cellular proliferation as well a reduction of apoptosis and, thus, the relative activation of ERK1 and ERK2 could have variable cellular effects in prostate carcinogenesis (Papatsoris et al., 2007). This evidence concerns the gene MAPK3 and male reproductive organ cancer.